Paramore Miriam J's Form 4 filing
OptimizeRx Corp (OPRX) · filed Nov 3, 2021
- Accession no.
- 0001213900-21-056471
- Filed
- Nov 3, 2021
- Trade date
- Nov 2, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.43M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Paramore Miriam JCIK 0001713156 | Officer (PRES. & CHIEF STRATEGY OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2021 | Common Stock | MOption exerciseAcquired | +15,000 | $7.51 | +$112,650 | 89,607 | Direct | |
| Nov 2, 2021 | Common Stock Pursuant to 10B5-1 Plan | SSaleDisposed | −15,000 | $95.45 | −$1,431,750 | 74,607 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2021 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 94,318 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.